WU
KRTX

Washington University’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Washington University’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,830
Closed -$2.88M – 10
2023
Q1 		$2.88M Buy
+15,830
New +$3.03M 0.76% 8

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Washington University's KRTX Position: Q2 2023 in Review

Washington University sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2023, closing a stake of 15,830 shares — an estimated $2.88M sold.

Washington University first reported a position in KRTX in Q1 2023 and held it in 1 quarter. The position peaked at $2.88M in Q1 2023. 289 funds tracked by Wall St. Rank hold KRTX as of Q2 2023.

  • Washington University reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Washington University sold 15,830 Karuna Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $2.88M.
  • Washington University first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Washington University's Karuna Therapeutics, Inc. Common Stock position peaked at $2.88M in Q1 2023.
  • 289 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Washington University's 13F filing for Q2 2023, filed 9 Aug 2023.